Abstract
Data from pharmacokinetic and pharmacodynamic studies indicate that the adverse clopidogrel - proton pump inhibitor (PPI) interaction may vary between PPIs, with pantoprazole considered relatively less problematic. We aimed to evaluate systematically whether individual PPIs differ in their risk for cardiovascular events when concomitantly administered with clopidogrel.
Original language | English |
---|---|
Pages (from-to) | 965-74 |
Number of pages | 10 |
Journal | International Journal of Cardiology |
Volume | 167 |
Issue number | 3 |
DOIs | |
Publication status | Published - 10 Aug 2013 |